(SQM) Sociedad Quimica y Minera - Overview
Exchange: NYSE •
Country: Chile •
Currency: USD •
Type: Common Stock •
ISIN: US8336351056
Stock: Fertilizers, Iodine, Lithium, Industrial Chemicals
Total Rating 67
Risk 90
Buy Signal 0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 46.9% |
| Relative Tail Risk | -4.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.19 |
| Alpha | 59.77 |
| Character TTM | |
|---|---|
| Beta | 0.987 |
| Beta Downside | 0.721 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.00% |
| CAGR/Max DD | -0.03 |
EPS (Earnings per Share)
Revenue
Description: SQM Sociedad Quimica y Minera March 04, 2026
Sociedad Química y Minera de Chile S.A. (SQM) is a Chilean company producing and selling specialty plant nutrients, iodine, and lithium products globally. The companys business model centers on extracting and processing natural resources to create high-value chemical compounds.
SQMs specialty plant nutrient segment includes various fertilizers sold under brands like Ultrasol and Qrop, catering to diverse agricultural needs. The iodine and derivatives segment serves medical, agricultural, and industrial applications, including X-ray contrast media and LCD screens. Iodine is a critical component in many advanced technological products.
The company is a significant producer of lithium carbonate and lithium hydroxide, essential for electric vehicle batteries and other industrial uses. The global demand for lithium is rapidly increasing due to the growth of the electric vehicle market. Additionally, SQM produces potassium sulfate and potassium chloride for crop nourishment and various industrial chemicals such as sodium nitrate and solar salts. SQM also engages in the exploration of copper, gold, and silver deposits.
For further detailed analysis of SQMs financial performance and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
- Lithium demand surge boosts revenue from EV battery production
- Global fertilizer prices impact nutrient segment profitability
- Iodine market stability supports specialty chemical sales
- Chilean mining regulations pose operational and cost risks
- Exchange rate fluctuations affect international sales and costs
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 524.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 5.31 > 1.0 |
| NWC/Revenue: 82.42% < 20% (prev 77.60%; Δ 4.82% < -1%) |
| CFO/TA 0.17 > 3% & CFO 2.03b > Net Income 524.5m |
| Net Debt (3.22b) to EBITDA (1.01b): 3.20 < 3 |
| Current Ratio: 2.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (285.7m) vs 12m ago 0.00% < -2% |
| Gross Margin: 27.69% > 18% (prev 0.30%; Δ 2739 % > 0.5%) |
| Asset Turnover: 37.59% > 50% (prev 42.22%; Δ -4.63% > 0%) |
| Interest Coverage Ratio: 5.37 > 6 (EBITDA TTM 1.01b / Interest Expense TTM 186.3m) |
Altman Z'' 4.59
| A: 0.30 (Total Current Assets 5.52b - Total Current Liabilities 1.96b) / Total Assets 11.73b |
| B: 0.33 (Retained Earnings 3.90b / Total Assets 11.73b) |
| C: 0.09 (EBIT TTM 999.7m / Avg Total Assets 11.51b) |
| D: 0.89 (Book Value of Equity 5.49b / Total Liabilities 6.19b) |
| Altman-Z'' Score: 4.59 = AA |
Beneish M -3.07
| DSRI: 1.19 (Receivables 630.4m/584.6m, Revenue 4.33b/4.77b) |
| GMI: 1.08 (GM 27.69% / 30.00%) |
| AQI: 0.86 (AQ_t 0.11 / AQ_t-1 0.13) |
| SGI: 0.91 (Revenue 4.33b / 4.77b) |
| TATA: -0.13 (NI 524.5m - CFO 2.03b) / TA 11.73b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of SQM shares?
As of March 09, 2026, the stock is trading at USD 70.39 with a total of 1,032,246 shares traded.
Over the past week, the price has changed by -6.93%, over one month by -1.07%, over three months by +16.46% and over the past year by +68.28%.
Over the past week, the price has changed by -6.93%, over one month by -1.07%, over three months by +16.46% and over the past year by +68.28%.
Is SQM a buy, sell or hold?
Sociedad Quimica y Minera has received a consensus analysts rating of 3.94.
Therefore, it is recommended to buy SQM.
- StrongBuy: 6
- Buy: 4
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the SQM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.1 | 8.1% |
| Analysts Target Price | 76.1 | 8.1% |
SQM Fundamental Data Overview March 06, 2026
P/E Forward = 18.1488
P/S = 4.4953
P/B = 3.5785
P/EG = 1.6961
Revenue TTM = 4.33b USD
EBIT TTM = 999.7m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 3.75b USD (from longTermDebt, last quarter)
Short Term Debt = 901.5m USD (from shortTermDebt, last quarter)
Debt = 4.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 22.89b USD (20.57b + Debt 4.71b - CCE 2.39b)
Interest Coverage Ratio = 5.37 (Ebit TTM 999.7m / Interest Expense TTM 186.3m)
EV/FCF = 348.7x (Enterprise Value 22.89b / FCF TTM 65.7m)
FCF Yield = 0.29% (FCF TTM 65.7m / Enterprise Value 22.89b)
FCF Margin = 1.52% (FCF TTM 65.7m / Revenue TTM 4.33b)
Net Margin = 12.12% (Net Income TTM 524.5m / Revenue TTM 4.33b)
Gross Margin = 27.69% ((Revenue TTM 4.33b - Cost of Revenue TTM 3.13b) / Revenue TTM)
Gross Margin QoQ = 29.48% (prev 24.32%)
Tobins Q-Ratio = 1.95 (Enterprise Value 22.89b / Total Assets 11.73b)
Interest Expense / Debt = 0.87% (Interest Expense 41.1m / Debt 4.71b)
Taxrate = 32.22% (85.6m / 265.6m)
NOPAT = 677.6m (EBIT 999.7m * (1 - 32.22%))
Current Ratio = 2.82 (Total Current Assets 5.52b / Total Current Liabilities 1.96b)
Debt / Equity = 0.86 (Debt 4.71b / totalStockholderEquity, last quarter 5.49b)
Debt / EBITDA = 3.20 (Net Debt 3.22b / EBITDA 1.01b)
Debt / FCF = 49.00 (Net Debt 3.22b / FCF TTM 65.7m)
Total Stockholder Equity = 5.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.56% (Net Income 524.5m / Total Assets 11.73b)
RoE = 9.87% (Net Income TTM 524.5m / Total Stockholder Equity 5.31b)
RoCE = 11.02% (EBIT 999.7m / Capital Employed (Equity 5.31b + L.T.Debt 3.75b))
RoIC = 6.79% (NOPAT 677.6m / Invested Capital 9.98b)
WACC = 7.88% (E(20.57b)/V(25.28b) * Re(9.55%) + D(4.71b)/V(25.28b) * Rd(0.87%) * (1-Tc(0.32)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.00%
[DCF] Terminal Value 70.77% ; FCFF base≈65.7m ; Y1≈43.1m ; Y5≈19.7m
[DCF] Fair Price = N/A (negative equity: EV 392.7m - Net Debt 3.22b = -2.82b; debt exceeds intrinsic value)
EPS Correlation: -54.73 | EPS CAGR: -32.47% | SUE: -0.08 | # QB: 0
Revenue Correlation: -67.59 | Revenue CAGR: 2.12% | SUE: 0.19 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.67 | Chg7d=+0.615 | Chg30d=+0.615 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.98 | Chg7d=+0.867 | Chg30d=+0.758 | Revisions Net=+2 | Growth EPS=+141.6% | Growth Revenue=+41.9%
EPS next Year (2027-12-31): EPS=5.35 | Chg7d=+0.520 | Chg30d=+0.217 | Revisions Net=+2 | Growth EPS=+7.5% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
P/S = 4.4953
P/B = 3.5785
P/EG = 1.6961
Revenue TTM = 4.33b USD
EBIT TTM = 999.7m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 3.75b USD (from longTermDebt, last quarter)
Short Term Debt = 901.5m USD (from shortTermDebt, last quarter)
Debt = 4.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 22.89b USD (20.57b + Debt 4.71b - CCE 2.39b)
Interest Coverage Ratio = 5.37 (Ebit TTM 999.7m / Interest Expense TTM 186.3m)
EV/FCF = 348.7x (Enterprise Value 22.89b / FCF TTM 65.7m)
FCF Yield = 0.29% (FCF TTM 65.7m / Enterprise Value 22.89b)
FCF Margin = 1.52% (FCF TTM 65.7m / Revenue TTM 4.33b)
Net Margin = 12.12% (Net Income TTM 524.5m / Revenue TTM 4.33b)
Gross Margin = 27.69% ((Revenue TTM 4.33b - Cost of Revenue TTM 3.13b) / Revenue TTM)
Gross Margin QoQ = 29.48% (prev 24.32%)
Tobins Q-Ratio = 1.95 (Enterprise Value 22.89b / Total Assets 11.73b)
Interest Expense / Debt = 0.87% (Interest Expense 41.1m / Debt 4.71b)
Taxrate = 32.22% (85.6m / 265.6m)
NOPAT = 677.6m (EBIT 999.7m * (1 - 32.22%))
Current Ratio = 2.82 (Total Current Assets 5.52b / Total Current Liabilities 1.96b)
Debt / Equity = 0.86 (Debt 4.71b / totalStockholderEquity, last quarter 5.49b)
Debt / EBITDA = 3.20 (Net Debt 3.22b / EBITDA 1.01b)
Debt / FCF = 49.00 (Net Debt 3.22b / FCF TTM 65.7m)
Total Stockholder Equity = 5.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.56% (Net Income 524.5m / Total Assets 11.73b)
RoE = 9.87% (Net Income TTM 524.5m / Total Stockholder Equity 5.31b)
RoCE = 11.02% (EBIT 999.7m / Capital Employed (Equity 5.31b + L.T.Debt 3.75b))
RoIC = 6.79% (NOPAT 677.6m / Invested Capital 9.98b)
WACC = 7.88% (E(20.57b)/V(25.28b) * Re(9.55%) + D(4.71b)/V(25.28b) * Rd(0.87%) * (1-Tc(0.32)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.00%
[DCF] Terminal Value 70.77% ; FCFF base≈65.7m ; Y1≈43.1m ; Y5≈19.7m
[DCF] Fair Price = N/A (negative equity: EV 392.7m - Net Debt 3.22b = -2.82b; debt exceeds intrinsic value)
EPS Correlation: -54.73 | EPS CAGR: -32.47% | SUE: -0.08 | # QB: 0
Revenue Correlation: -67.59 | Revenue CAGR: 2.12% | SUE: 0.19 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.67 | Chg7d=+0.615 | Chg30d=+0.615 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.98 | Chg7d=+0.867 | Chg30d=+0.758 | Revisions Net=+2 | Growth EPS=+141.6% | Growth Revenue=+41.9%
EPS next Year (2027-12-31): EPS=5.35 | Chg7d=+0.520 | Chg30d=+0.217 | Revisions Net=+2 | Growth EPS=+7.5% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)